Burlington D B, Meiklejohn G, Mostow S R
J Antimicrob Chemother. 1983 Jan;11(1):7-14. doi: 10.1093/jac/11.1.7.
The anti-influenza A activities of amantadine and ribavirin were investigated separately and in combination. Ferret tracheal ciliated epithelium was continuously exposed to the drugs at concentrations (0.25, 0.5, and 1 mg/l) comparable to those found in human serum after oral administration. Each drug alone produced a modest delay in A/Alaska/6/77 (H3N2) induced cytopathic effect. The combination of drugs synergistically delayed cytopathic effect. At 1 mg/l of each, cytopathic effect was prevented in 75% of rings for the 28-day duration of the experiment. This effect was greater than that of 32 mg/l of amantadine or 64 mg/l of ribavirin as single antiviral drugs. Peak virus production was suppressed 4.4 log-fold by the combination of 1 mg/l of each drug. This is in contrast to amantadine alone which suppressed peak virus production by 1 log-fold and ribavirin along which at 1 mg/l suppressed peak virus production by 1.9 log-fold. At lower concentrations, the drugs were at least additive in suppression of virus production.
分别对金刚烷胺和利巴韦林的抗甲型流感活性以及它们的联合作用进行了研究。将雪貂气管纤毛上皮持续暴露于与口服给药后人体血清中浓度相当的药物浓度(0.25、0.5和1毫克/升)下。每种药物单独使用时,均可适度延迟A/阿拉斯加/6/77(H3N2)诱导的细胞病变效应。联合用药可协同延迟细胞病变效应。在每种药物浓度为1毫克/升时,在实验的28天期间,75%的环中细胞病变效应得到预防。该效应大于作为单一抗病毒药物的32毫克/升金刚烷胺或64毫克/升利巴韦林的效应。每种药物浓度为1毫克/升时联合用药可使病毒产生峰值受到4.4对数倍的抑制。相比之下,单独使用金刚烷胺可使病毒产生峰值受到1对数倍的抑制,单独使用利巴韦林在浓度为1毫克/升时可使病毒产生峰值受到1.9对数倍的抑制。在较低浓度下,药物在抑制病毒产生方面至少具有相加作用。